 | • レポートコード：MRC308GR10550 • 出版社/出版日：GlobalInfoResearch / 2023年8月14日 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の医薬品用メシル酸エリブリンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の医薬品用メシル酸エリブリン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 医薬品用メシル酸エリブリンの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
医薬品用メシル酸エリブリン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・純度≧99%、純度<99%
用途別セグメント
・溶液、その他
主要な市場プレーヤー
・Natco Pharma Ltd、Emcure Pharmaceuticals Ltd、Dr Reddys Laboratories Ltd、Wisdom Pharmaceutical Co Ltd、Formosa Laboratories Inc、Eurofins Cdmo Alphora Inc、Xiling Lab Co Ltd、Chongqing Sintaho Pharmaceutical Co Ltd、Lianyungang Runzhong Pharmaceutical Co Ltd、Zhejiang Raybow Pharmaceutical Co Ltd、Brightgene Bio-Medical Technology Co Ltd
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、医薬品用メシル酸エリブリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医薬品用メシル酸エリブリンメーカーの企業概要、2019年～2022年までの医薬品用メシル酸エリブリンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医薬品用メシル酸エリブリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別医薬品用メシル酸エリブリンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの医薬品用メシル酸エリブリンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での医薬品用メシル酸エリブリン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および医薬品用メシル酸エリブリンの産業チェーンを掲載しています。
・第14、15章では、医薬品用メシル酸エリブリンの販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
- 医薬品用メシル酸エリブリンの概要
- 種類別分析（2018年vs2022年vs2029年）：純度≧99%、純度<99%
- 用途別分析（2018年vs2022年vs2029年）：溶液、その他
- 世界の医薬品用メシル酸エリブリン市場規模・予測
- 世界の医薬品用メシル酸エリブリン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Natco Pharma Ltd、Emcure Pharmaceuticals Ltd、Dr Reddys Laboratories Ltd、Wisdom Pharmaceutical Co Ltd、Formosa Laboratories Inc、Eurofins Cdmo Alphora Inc、Xiling Lab Co Ltd、Chongqing Sintaho Pharmaceutical Co Ltd、Lianyungang Runzhong Pharmaceutical Co Ltd、Zhejiang Raybow Pharmaceutical Co Ltd、Brightgene Bio-Medical Technology Co Ltd
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：純度≧99%、純度<99%
・用途別分析2018年-2029年：溶液、その他
・医薬品用メシル酸エリブリンの北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・医薬品用メシル酸エリブリンのヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・医薬品用メシル酸エリブリンのアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・医薬品用メシル酸エリブリンの南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・医薬品用メシル酸エリブリンの中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical Grade Eribulin Mesylate
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity≥99%
1.3.3 Purity<99%
1.4 Market Analysis by Application
1.4.1 Overview: Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Solution
1.4.3 Others
1.5 Global Pharmaceutical Grade Eribulin Mesylate Market Size & Forecast
1.5.1 Global Pharmaceutical Grade Eribulin Mesylate Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity (2018-2029)
1.5.3 Global Pharmaceutical Grade Eribulin Mesylate Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Natco Pharma Ltd
2.1.1 Natco Pharma Ltd Details
2.1.2 Natco Pharma Ltd Major Business
2.1.3 Natco Pharma Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
2.1.4 Natco Pharma Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Natco Pharma Ltd Recent Developments/Updates
2.2 Emcure Pharmaceuticals Ltd
2.2.1 Emcure Pharmaceuticals Ltd Details
2.2.2 Emcure Pharmaceuticals Ltd Major Business
2.2.3 Emcure Pharmaceuticals Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
2.2.4 Emcure Pharmaceuticals Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Emcure Pharmaceuticals Ltd Recent Developments/Updates
2.3 Dr Reddys Laboratories Ltd
2.3.1 Dr Reddys Laboratories Ltd Details
2.3.2 Dr Reddys Laboratories Ltd Major Business
2.3.3 Dr Reddys Laboratories Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
2.3.4 Dr Reddys Laboratories Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Dr Reddys Laboratories Ltd Recent Developments/Updates
2.4 Wisdom Pharmaceutical Co Ltd
2.4.1 Wisdom Pharmaceutical Co Ltd Details
2.4.2 Wisdom Pharmaceutical Co Ltd Major Business
2.4.3 Wisdom Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
2.4.4 Wisdom Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Wisdom Pharmaceutical Co Ltd Recent Developments/Updates
2.5 Formosa Laboratories Inc
2.5.1 Formosa Laboratories Inc Details
2.5.2 Formosa Laboratories Inc Major Business
2.5.3 Formosa Laboratories Inc Pharmaceutical Grade Eribulin Mesylate Product and Services
2.5.4 Formosa Laboratories Inc Pharmaceutical Grade Eribulin Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Formosa Laboratories Inc Recent Developments/Updates
2.6 Eurofins Cdmo Alphora Inc
2.6.1 Eurofins Cdmo Alphora Inc Details
2.6.2 Eurofins Cdmo Alphora Inc Major Business
2.6.3 Eurofins Cdmo Alphora Inc Pharmaceutical Grade Eribulin Mesylate Product and Services
2.6.4 Eurofins Cdmo Alphora Inc Pharmaceutical Grade Eribulin Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Eurofins Cdmo Alphora Inc Recent Developments/Updates
2.7 Xiling Lab Co Ltd
2.7.1 Xiling Lab Co Ltd Details
2.7.2 Xiling Lab Co Ltd Major Business
2.7.3 Xiling Lab Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
2.7.4 Xiling Lab Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Xiling Lab Co Ltd Recent Developments/Updates
2.8 Chongqing Sintaho Pharmaceutical Co Ltd
2.8.1 Chongqing Sintaho Pharmaceutical Co Ltd Details
2.8.2 Chongqing Sintaho Pharmaceutical Co Ltd Major Business
2.8.3 Chongqing Sintaho Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
2.8.4 Chongqing Sintaho Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Chongqing Sintaho Pharmaceutical Co Ltd Recent Developments/Updates
2.9 Lianyungang Runzhong Pharmaceutical Co Ltd
2.9.1 Lianyungang Runzhong Pharmaceutical Co Ltd Details
2.9.2 Lianyungang Runzhong Pharmaceutical Co Ltd Major Business
2.9.3 Lianyungang Runzhong Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
2.9.4 Lianyungang Runzhong Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lianyungang Runzhong Pharmaceutical Co Ltd Recent Developments/Updates
2.10 Zhejiang Raybow Pharmaceutical Co Ltd
2.10.1 Zhejiang Raybow Pharmaceutical Co Ltd Details
2.10.2 Zhejiang Raybow Pharmaceutical Co Ltd Major Business
2.10.3 Zhejiang Raybow Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
2.10.4 Zhejiang Raybow Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Zhejiang Raybow Pharmaceutical Co Ltd Recent Developments/Updates
2.11 Brightgene Bio-Medical Technology Co Ltd
2.11.1 Brightgene Bio-Medical Technology Co Ltd Details
2.11.2 Brightgene Bio-Medical Technology Co Ltd Major Business
2.11.3 Brightgene Bio-Medical Technology Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
2.11.4 Brightgene Bio-Medical Technology Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Brightgene Bio-Medical Technology Co Ltd Recent Developments/Updates
3 Competitive Environment: Pharmaceutical Grade Eribulin Mesylate by Manufacturer
3.1 Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pharmaceutical Grade Eribulin Mesylate Revenue by Manufacturer (2018-2023)
3.3 Global Pharmaceutical Grade Eribulin Mesylate Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pharmaceutical Grade Eribulin Mesylate by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pharmaceutical Grade Eribulin Mesylate Manufacturer Market Share in 2022
3.4.2 Top 6 Pharmaceutical Grade Eribulin Mesylate Manufacturer Market Share in 2022
3.5 Pharmaceutical Grade Eribulin Mesylate Market: Overall Company Footprint Analysis
3.5.1 Pharmaceutical Grade Eribulin Mesylate Market: Region Footprint
3.5.2 Pharmaceutical Grade Eribulin Mesylate Market: Company Product Type Footprint
3.5.3 Pharmaceutical Grade Eribulin Mesylate Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pharmaceutical Grade Eribulin Mesylate Market Size by Region
4.1.1 Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Region (2018-2029)
4.1.2 Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Region (2018-2029)
4.1.3 Global Pharmaceutical Grade Eribulin Mesylate Average Price by Region (2018-2029)
4.2 North America Pharmaceutical Grade Eribulin Mesylate Consumption Value (2018-2029)
4.3 Europe Pharmaceutical Grade Eribulin Mesylate Consumption Value (2018-2029)
4.4 Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Consumption Value (2018-2029)
4.5 South America Pharmaceutical Grade Eribulin Mesylate Consumption Value (2018-2029)
4.6 Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2029)
5.2 Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Type (2018-2029)
5.3 Global Pharmaceutical Grade Eribulin Mesylate Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2029)
6.2 Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Application (2018-2029)
6.3 Global Pharmaceutical Grade Eribulin Mesylate Average Price by Application (2018-2029)
7 North America
7.1 North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2029)
7.2 North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2029)
7.3 North America Pharmaceutical Grade Eribulin Mesylate Market Size by Country
7.3.1 North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Country (2018-2029)
7.3.2 North America Pharmaceutical Grade Eribulin Mesylate Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2029)
8.2 Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2029)
8.3 Europe Pharmaceutical Grade Eribulin Mesylate Market Size by Country
8.3.1 Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Country (2018-2029)
8.3.2 Europe Pharmaceutical Grade Eribulin Mesylate Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2029)
10.2 South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2029)
10.3 South America Pharmaceutical Grade Eribulin Mesylate Market Size by Country
10.3.1 South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Country (2018-2029)
10.3.2 South America Pharmaceutical Grade Eribulin Mesylate Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pharmaceutical Grade Eribulin Mesylate Market Drivers
12.2 Pharmaceutical Grade Eribulin Mesylate Market Restraints
12.3 Pharmaceutical Grade Eribulin Mesylate Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pharmaceutical Grade Eribulin Mesylate and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pharmaceutical Grade Eribulin Mesylate
13.3 Pharmaceutical Grade Eribulin Mesylate Production Process
13.4 Pharmaceutical Grade Eribulin Mesylate Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pharmaceutical Grade Eribulin Mesylate Typical Distributors
14.3 Pharmaceutical Grade Eribulin Mesylate Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Natco Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Natco Pharma Ltd Major Business
Table 5. Natco Pharma Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
Table 6. Natco Pharma Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Natco Pharma Ltd Recent Developments/Updates
Table 8. Emcure Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Emcure Pharmaceuticals Ltd Major Business
Table 10. Emcure Pharmaceuticals Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
Table 11. Emcure Pharmaceuticals Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Emcure Pharmaceuticals Ltd Recent Developments/Updates
Table 13. Dr Reddys Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Dr Reddys Laboratories Ltd Major Business
Table 15. Dr Reddys Laboratories Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
Table 16. Dr Reddys Laboratories Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Dr Reddys Laboratories Ltd Recent Developments/Updates
Table 18. Wisdom Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 19. Wisdom Pharmaceutical Co Ltd Major Business
Table 20. Wisdom Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
Table 21. Wisdom Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Wisdom Pharmaceutical Co Ltd Recent Developments/Updates
Table 23. Formosa Laboratories Inc Basic Information, Manufacturing Base and Competitors
Table 24. Formosa Laboratories Inc Major Business
Table 25. Formosa Laboratories Inc Pharmaceutical Grade Eribulin Mesylate Product and Services
Table 26. Formosa Laboratories Inc Pharmaceutical Grade Eribulin Mesylate Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Formosa Laboratories Inc Recent Developments/Updates
Table 28. Eurofins Cdmo Alphora Inc Basic Information, Manufacturing Base and Competitors
Table 29. Eurofins Cdmo Alphora Inc Major Business
Table 30. Eurofins Cdmo Alphora Inc Pharmaceutical Grade Eribulin Mesylate Product and Services
Table 31. Eurofins Cdmo Alphora Inc Pharmaceutical Grade Eribulin Mesylate Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Eurofins Cdmo Alphora Inc Recent Developments/Updates
Table 33. Xiling Lab Co Ltd Basic Information, Manufacturing Base and Competitors
Table 34. Xiling Lab Co Ltd Major Business
Table 35. Xiling Lab Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
Table 36. Xiling Lab Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Xiling Lab Co Ltd Recent Developments/Updates
Table 38. Chongqing Sintaho Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Chongqing Sintaho Pharmaceutical Co Ltd Major Business
Table 40. Chongqing Sintaho Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
Table 41. Chongqing Sintaho Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Chongqing Sintaho Pharmaceutical Co Ltd Recent Developments/Updates
Table 43. Lianyungang Runzhong Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Lianyungang Runzhong Pharmaceutical Co Ltd Major Business
Table 45. Lianyungang Runzhong Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
Table 46. Lianyungang Runzhong Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Lianyungang Runzhong Pharmaceutical Co Ltd Recent Developments/Updates
Table 48. Zhejiang Raybow Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Zhejiang Raybow Pharmaceutical Co Ltd Major Business
Table 50. Zhejiang Raybow Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
Table 51. Zhejiang Raybow Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Zhejiang Raybow Pharmaceutical Co Ltd Recent Developments/Updates
Table 53. Brightgene Bio-Medical Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Brightgene Bio-Medical Technology Co Ltd Major Business
Table 55. Brightgene Bio-Medical Technology Co Ltd Pharmaceutical Grade Eribulin Mesylate Product and Services
Table 56. Brightgene Bio-Medical Technology Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Brightgene Bio-Medical Technology Co Ltd Recent Developments/Updates
Table 58. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 59. Global Pharmaceutical Grade Eribulin Mesylate Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Pharmaceutical Grade Eribulin Mesylate Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 61. Market Position of Manufacturers in Pharmaceutical Grade Eribulin Mesylate, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Pharmaceutical Grade Eribulin Mesylate Production Site of Key Manufacturer
Table 63. Pharmaceutical Grade Eribulin Mesylate Market: Company Product Type Footprint
Table 64. Pharmaceutical Grade Eribulin Mesylate Market: Company Product Application Footprint
Table 65. Pharmaceutical Grade Eribulin Mesylate New Market Entrants and Barriers to Market Entry
Table 66. Pharmaceutical Grade Eribulin Mesylate Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Region (2018-2023) & (Tons)
Table 68. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Region (2024-2029) & (Tons)
Table 69. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Pharmaceutical Grade Eribulin Mesylate Average Price by Region (2018-2023) & (US$/Ton)
Table 72. Global Pharmaceutical Grade Eribulin Mesylate Average Price by Region (2024-2029) & (US$/Ton)
Table 73. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2023) & (Tons)
Table 74. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2024-2029) & (Tons)
Table 75. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Pharmaceutical Grade Eribulin Mesylate Average Price by Type (2018-2023) & (US$/Ton)
Table 78. Global Pharmaceutical Grade Eribulin Mesylate Average Price by Type (2024-2029) & (US$/Ton)
Table 79. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2023) & (Tons)
Table 80. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2024-2029) & (Tons)
Table 81. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Pharmaceutical Grade Eribulin Mesylate Average Price by Application (2018-2023) & (US$/Ton)
Table 84. Global Pharmaceutical Grade Eribulin Mesylate Average Price by Application (2024-2029) & (US$/Ton)
Table 85. North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2023) & (Tons)
Table 86. North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2024-2029) & (Tons)
Table 87. North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2023) & (Tons)
Table 88. North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2024-2029) & (Tons)
Table 89. North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Country (2018-2023) & (Tons)
Table 90. North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Country (2024-2029) & (Tons)
Table 91. North America Pharmaceutical Grade Eribulin Mesylate Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Pharmaceutical Grade Eribulin Mesylate Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2023) & (Tons)
Table 94. Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2024-2029) & (Tons)
Table 95. Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2023) & (Tons)
Table 96. Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2024-2029) & (Tons)
Table 97. Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Country (2018-2023) & (Tons)
Table 98. Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Country (2024-2029) & (Tons)
Table 99. Europe Pharmaceutical Grade Eribulin Mesylate Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Pharmaceutical Grade Eribulin Mesylate Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2023) & (Tons)
Table 102. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2024-2029) & (Tons)
Table 103. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2023) & (Tons)
Table 104. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2024-2029) & (Tons)
Table 105. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Region (2018-2023) & (Tons)
Table 106. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Region (2024-2029) & (Tons)
Table 107. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2023) & (Tons)
Table 110. South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2024-2029) & (Tons)
Table 111. South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2023) & (Tons)
Table 112. South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2024-2029) & (Tons)
Table 113. South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Country (2018-2023) & (Tons)
Table 114. South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Country (2024-2029) & (Tons)
Table 115. South America Pharmaceutical Grade Eribulin Mesylate Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Pharmaceutical Grade Eribulin Mesylate Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2018-2023) & (Tons)
Table 118. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Type (2024-2029) & (Tons)
Table 119. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2018-2023) & (Tons)
Table 120. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Application (2024-2029) & (Tons)
Table 121. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Region (2018-2023) & (Tons)
Table 122. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity by Region (2024-2029) & (Tons)
Table 123. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Pharmaceutical Grade Eribulin Mesylate Raw Material
Table 126. Key Manufacturers of Pharmaceutical Grade Eribulin Mesylate Raw Materials
Table 127. Pharmaceutical Grade Eribulin Mesylate Typical Distributors
Table 128. Pharmaceutical Grade Eribulin Mesylate Typical Customers
List of Figures
Figure 1. Pharmaceutical Grade Eribulin Mesylate Picture
Figure 2. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value Market Share by Type in 2022
Figure 4. Purity≥99% Examples
Figure 5. Purity<99% Examples
Figure 6. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value Market Share by Application in 2022
Figure 8. Solution Examples
Figure 9. Others Examples
Figure 10. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity (2018-2029) & (Tons)
Figure 13. Global Pharmaceutical Grade Eribulin Mesylate Average Price (2018-2029) & (US$/Ton)
Figure 14. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Pharmaceutical Grade Eribulin Mesylate by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Pharmaceutical Grade Eribulin Mesylate Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Pharmaceutical Grade Eribulin Mesylate Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Pharmaceutical Grade Eribulin Mesylate Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Pharmaceutical Grade Eribulin Mesylate Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Pharmaceutical Grade Eribulin Mesylate Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Pharmaceutical Grade Eribulin Mesylate Average Price by Type (2018-2029) & (US$/Ton)
Figure 29. Global Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Pharmaceutical Grade Eribulin Mesylate Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Pharmaceutical Grade Eribulin Mesylate Average Price by Application (2018-2029) & (US$/Ton)
Figure 32. North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Pharmaceutical Grade Eribulin Mesylate Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Pharmaceutical Grade Eribulin Mesylate Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Pharmaceutical Grade Eribulin Mesylate Consumption Value Market Share by Region (2018-2029)
Figure 52. China Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Pharmaceutical Grade Eribulin Mesylate Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Pharmaceutical Grade Eribulin Mesylate Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Pharmaceutical Grade Eribulin Mesylate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Pharmaceutical Grade Eribulin Mesylate Market Drivers
Figure 73. Pharmaceutical Grade Eribulin Mesylate Market Restraints
Figure 74. Pharmaceutical Grade Eribulin Mesylate Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Pharmaceutical Grade Eribulin Mesylate in 2022
Figure 77. Manufacturing Process Analysis of Pharmaceutical Grade Eribulin Mesylate
Figure 78. Pharmaceutical Grade Eribulin Mesylate Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source